Related Experiment Video
Updated: Jun 2, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Accelerated immunotherapy schedules and premedication.
Christopher W Calabria1, Linda Cox
1ENTAA Care, PA, 203 Hospital Drive Suite 200, Glen Burnie, MD 21061, USA. chriscalabs@aol.com
Accelerated subcutaneous immunotherapy, including rush and cluster schedules, reduces office visits by administering allergen injections rapidly. These methods achieve maintenance doses in weeks, offering a faster path to allergy treatment.
Area of Science:
- Allergy and Immunology
- Immunotherapy Research
Background:
- Subcutaneous immunotherapy (SCIT) involves buildup and maintenance phases.
- Traditional SCIT requires numerous patient visits over an extended period.
Purpose of the Study:
- To describe accelerated immunotherapy schedules.
- To highlight the benefits of reduced office visits with these protocols.
Main Methods:
- Review of common accelerated immunotherapy schedules in the US: rush and cluster immunotherapy.
- Description of cluster immunotherapy: sequential allergen injections on single, nonconsecutive days.
- Description of rush immunotherapy: rapid administration of higher doses over 1-3 days.
Main Results:
- Accelerated schedules significantly reduce the time to reach the maintenance immunotherapy dose.
- Cluster immunotherapy reaches maintenance doses in 4-8 weeks.
- Rush immunotherapy achieves maintenance doses within 1-3 days.
Conclusions:
- Accelerated immunotherapy protocols, such as rush and cluster schedules, offer an efficient alternative to traditional SCIT.
- These methods decrease the number of required patient visits, potentially improving treatment adherence and accessibility.
More Related Videos
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
05:44A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
Published on: December 9, 2022
Related Concept Videos
Tumor Immunotherapy
Vaccinations